3,605,067 Shares in Acadia Healthcare Company, Inc. $ACHC Purchased by Jefferies Financial Group Inc.

Key Points

• Jefferies Financial Group acquired 3.61 million Acadia Healthcare shares worth approximately $106.5 million, representing about 3.87% of the company and 0.7% of Jefferies’ holdings.
• Other major investors, including BlackRock, Goldman Sachs, Wellington Management, Vaughan Nelson and Deutsche Bank, also increased or initiated positions in Acadia Healthcare.
• Acadia beat quarterly earnings and revenue estimates, reporting $0.38 EPS and $865.84 million in revenue, while analysts maintain an average “Hold” rating with a $29.85 price target.

Jefferies Financial Group Inc. purchased a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 3,605,067 shares of the company's stock, valued at approximately $106,458,000. Acadia Healthcare comprises 0.7% of Jefferies Financial Group Inc.'s holdings, making the stock its 12th largest position. Jefferies Financial Group Inc. owned approximately 3.87% of Acadia Healthcare as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently bought and sold shares of the stock. BlackRock Inc. bought a new stake in shares of Acadia Healthcare during the second quarter worth approximately $441,685,000. Goldman Sachs Group Inc. lifted its holdings in Acadia Healthcare by 417.8% during the 4th quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company's stock worth $67,099,000 after purchasing an additional 3,815,471 shares during the last quarter. Wellington Management Group LLP boosted its stake in Acadia Healthcare by 24.9% in the 4th quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company's stock valued at $167,077,000 after purchasing an additional 2,350,760 shares during the period. Vaughan Nelson Investment Management L.P. acquired a new position in Acadia Healthcare in the 1st quarter valued at $43,017,000. Finally, Deutsche Bank AG acquired a new position in Acadia Healthcare in the 2nd quarter valued at $49,746,000.

Acadia Healthcare Stock Performance

NASDAQ:ACHC opened at $30.22 on Friday. The company has a market cap of $2.81 billion, a price-to-earnings ratio of -2.43, a PEG ratio of 9.85 and a beta of 0.64. Acadia Healthcare Company, Inc. has a fifty-two week low of $11.43 and a fifty-two week high of $35.83. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.57 and a current ratio of 1.57. The stock has a fifty day moving average price of $30.39 and a 200-day moving average price of $26.04.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, topping analysts' consensus estimates of $0.35 by $0.03. The company had revenue of $865.84 million for the quarter, compared to analysts' expectations of $844.19 million. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.Acadia Healthcare's revenue was down .4% on a year-over-year basis. During the same quarter last year, the business earned $0.83 earnings per share. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, equities analysts anticipate that Acadia Healthcare Company, Inc. will post 1.55 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the company. Royal Bank Of Canada lifted their target price on Acadia Healthcare from $28.00 to $31.00 and gave the stock an "outperform" rating in a report on Monday, May 4th. TD Cowen upped their price target on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a "buy" rating in a research note on Tuesday, July 14th. Barclays raised their price target on shares of Acadia Healthcare from $25.00 to $32.00 and gave the stock an "equal weight" rating in a research report on Thursday, July 30th. Cantor Fitzgerald reissued a "neutral" rating on shares of Acadia Healthcare in a report on Wednesday, July 29th. Finally, Raymond James Financial upgraded shares of Acadia Healthcare from an "outperform" rating to a "strong-buy" rating and set a $39.00 target price on the stock in a research report on Monday, May 4th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $29.85.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source